FDA Investigator Lei Zhang, PhD
Lei Zhang, PhD has inspections in 3 countries as of 18 Apr 2023. Lei Zhang, PhD has collaborated with a combinined 1229 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
18 Apr 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Iceland,
Taiwan
Co-Investigator(s):
Adam R Cooke,
Amy C Jordan,
Amy N Chen,
Arsen Karapetyan,
Bonita S Chester,
Burnell M Henry,
Calvin B Koerner,
Carr Sharpe,
CDR Thomas R Berry, PPh,
Cynthia Jim, CSO,
Daryl A Dewoskin,
Devaughn Edwards,
Dien N Nguyen,
Donald C Obenhuber, PhD,
Dr. Ralph M Bernstein, PhD,
Edmund F Mrak, Jr,
Gilbert T Salud,
Hai Lien T Phung,
Ibad U Khan,
Jacek Cieslak, PhD,
James R Evans,
Jason F Chancey,
Jeffrey P Raimondi,
Jie He,
Jose Acruz Gonzalez,
Jose E Melendez, DDC,
Joseph F Owens,
Joseph Kutze, PhD,
Julie D Bringger,
Karen A Briggs,
Kirsten L Vadheim, PhD,
Laura I Salazar, PhD,
Leiyun Boone, PhD,
Lois K Gross,
Madushini Dharmasena, PhD,
Maria Joselopez Barragan, PhD,
Marion Michaelis,
Mark R Mcclain,
Megan A Haggerty,
Michael Shanks, MS,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Nealie C Newberger,
Prabhu P Raju,
Priscilla M Pastrana,
Rebecca Rodriguez,
Reyes Candau Chacon, PhD,
Richard Ledwidge (nmi), PhD,
Robert D Tollefsen,
Robert W Jennings,
Sean R Marcsisin,
Seneca D Toms,
Sidney B Priesmeyer,
Stacey S Degarmo,
Steven Fong, MS, PhD,
Susan M Jackson,
Tamara M Casselman,
Thuy T Nguyen, LCDR,
Viviana Matta,
Wayne E Seifert,
William Hallett, PhD,
Yetao Jin, PhD,
Zhao Wang, PhD,
Zhihao Qiu (Peter), PhD,
Ziyang Su, PhD
Lei Zhang, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2004 | EIR | Biogen MA Inc. - EIR, 2004-08-27 |
April, 2019 | FDA 483 | Immunex Rhode Island Corporation - Form 483, 2019-04-19 |
August, 2004 | EIR | Biogen Idec, Inc. - EIR, 2004-11-05 |
March, 2023 | FDA 483 | Alvotech Hf - Form 483, 2023-03-17 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more